Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more) Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News JFT Strategies Fund T.JFS.UN

Alternate Symbol(s):  JFTSF

JFT Strategies Fund (the Fund) is a Canada-based investment trust. The Fund's investment objective is to maximize return on investment to unitholders while seeking to mitigate market risk and volatility by investing in an actively managed portfolio of long and short positions in any one or a combination of equities, debt securities or other securities. The Company's portfolio manager is Timelo... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:JFS.UN)

CI Global Asset Management Announces Confirmed Annual Reinvested Distributions for JFT Strategies Fund

Business Wire January 5, 2024

CI Global Asset Management Announces Estimated Annual Reinvested Distributions for JFT Strategies Fund

Business Wire November 27, 2023

JFT Strategies Fund Launches At-The-Market Equity Program

Business Wire March 1, 2023

CI Global Asset Management Announces Confirmed Annual Reinvested Distributions for JFT Strategies Fund

Business Wire January 6, 2023

CI Global Asset Management Announces Estimated Annual Reinvested Distributions for JFT Strategies Fund

Business Wire December 5, 2022

CI Global Asset Management Announces Confirmed Annual Reinvested Distributions for JFT Strategies Fund

Business Wire January 7, 2022

CI Global Asset Management Announces Estimated Annual Reinvested Distributions for JFT Strategies Fund

Business Wire December 9, 2021

JFT Strategies Fund Confirms Distributions for Year-End 2019

Canada NewsWire January 10, 2020

CI First Asset Closed-End Fund Estimated 2019 Annual Special Distributions

Canada NewsWire December 18, 2019
View More News ››

Opinion & Analysis (TSX:JFS.UN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:JFS.UN)

Keeping up with the market

Since Dec JFT is up another 3.00. Dividends plus growth is a good combination.
gasoholic - February 9, 2021

JFT and Covid

At present price of 19.70 we have share appreciation of 6.00 at end Feb pre-covid. The covid low of April was 11.70. JFT did a good job...
gasoholic - December 25, 2020

Much appreciated

Making between 14 to 15 % per annum in the last 7 years or so . Don't look at the dividend rate and stock price to verify that...
gasoholic - September 28, 2019
View more Bullboard ››

Theralase Technologies Inc.

Theralase Technologies Inc.

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ...
View More »